Skip to main content


Table 3 – Treatment modality prescribed in studied population

From: Etiology of chronic urticaria: the Ecuadorian experience

Treatment Overall patients (n = 112) n (%)
Sg H1-antihisatmine alone 50 (44.6)
Sg H1-antihisatmine + another drug 47 (42.0)
Fg H1-antihistamine + Sg H1-antihisatmine 12 (10.7)
Fg H1-antihisatmine 3 (2.7)
  1. All data are presented as frequencies and percentages. The chi-square goodness-of-fit test indicated that the proportions of treatment modalities prescribed in the study were statistically significant (p = 0.00). Fg H1-antihistamine, first-generation H1 antihistamine; Sg H1-antihisatmine, second-generation H1 antihistamine